• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIO-RAD LABORATORIES MRSASELECTII

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIO-RAD LABORATORIES MRSASELECTII Back to Search Results
Catalog Number 63758
Device Problems Material Discolored (1170); Incorrect Or Inadequate Test Results (2456)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 05/30/2018
Event Type  malfunction  
Event Description
On (b)(6) 2018, (b)(6) laboratories - (b)(4) operations was made aware of an issue with (b)(6) select and (b)(6) selectii media plates.These products are selective and differential chromogenic media for the qualitative detection of (b)(6) colonies.Following reports from three customers located outside of the u.S., concerning an abnormal coloration of certain agar plates and the growth of non-characteristic (b)(6) colonies, bio-rad laboratories (infectious disease division, located in (b)(4)) conducted an investigation and confirmed that certain lots may be at risk for this issue.To date, (b)(6) laboratories infectious disease division has identified the following key features of this product issue: the origin of the problem is isolated to certain raw materials.The observation of a non-characteristic coloration of agar and non-characteristic (b)(6) colonies (colonies without any pink color development) occurs when the media plates have been exposed to light for prolonged periods during use and storage.For (b)(6) select, the issue presents after exposure periods greater than 2 hours.For (b)(6) select ii, the issue presents after exposure periods greater than 4 hours.Media plates with abnormal coloration may be visually identified by the user and may be detected prior to inoculation.If plates were exposed to light for time periods exceeding those stated above, then (b)(6) colonies may appear white to yellow instead of the pink characteristic color, or colony growth may be delayed.As a result, there is a risk of misinterpretation of the result (possible (b)(6)).In order to mitigate risk to results, bio-rad laboratories has recommended the following actions to all customers, distributed in the form of a customer letter: -as already recommended in the package insert, please ensure that exposure of agar plates to light is minimized, both before and during incubation, with the added time restrictions as follows: for (b)(6) select, do not expose the agar plates to light for more than 2 hours during storage, warming, incubation, and reading.For (b)(6) selectii, do not expose the agar plates to light for more than 4 hours during storage, warming, incubation, and reading.·do not use agar with a change in color from white to an orange-pinkish shade.·as recommended in the package insert, if in doubt, confirm the identification of colonies by coagulase test or pastorex staph-plus.The initial complaint was received from a customer in (b)(6) on the outside-u.S.Version of (b)(6) select ii (cat.No.63759).A subsequent complaint was received from a (b)(6) customer on the outside-u.S version of (b)(6) select (cat.No.63757).Therefore, bio-rad is filing two u.S.Mdr reports for the u.S.Version of (b)(6) select and (b)(6) selectii (cat no.63747 and 63758, respectively) even though no incidents were reported involving u.S.Versions of these devices.This decision is made as per section 4.11.3 of the fda guidance "medical device reporting for manufacturers," which states that an event that occurs in a foreign country is reportable if the device in question is similar to a device cleared in the u.S.Investigation at the bio-rad laboratories (b)(4) location, which occurred subsequent to the initial complaint, has indicated that raw materials implicated in the enhanced light sensitivity issue were also used in both (b)(6) select and (b)(6) select ii products distributed both outside-u.S.And within u.S.Although no complaints have been received against the u.S.Version of (b)(6) selectii (cat.No.63758), this report is being submitted in order to exercise an abundance of caution and to satisfy the requirement as described in section 4.11.3 of the aforementioned guidance.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MRSASELECTII
Type of Device
MRSASELECTII
Manufacturer (Section D)
BIO-RAD LABORATORIES
3, boulevard raymond poincare
marnes-la-coquette, 92430
FR  92430
Manufacturer (Section G)
BIO-RAD LABORATORIES
3, boulevard raymond poincare
marnes-la-coquette, 92430
FR   92430
Manufacturer Contact
david bhend
6565 185th ave ne
redmond, WA 98052
4254981758
MDR Report Key7607927
MDR Text Key112157963
Report Number3022521-2018-00006
Device Sequence Number1
Product Code JSO
UDI-Device Identifier03610521536208
UDI-Public03610521536208
Combination Product (y/n)N
PMA/PMN Number
K171061
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial
Report Date 06/15/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/15/2018
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator No Information
Device Expiration Date06/10/2018
Device Catalogue Number63758
Device Lot Number64177778
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Was Device Evaluated by Manufacturer? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
-
-